Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
9.40 EUR
765.62 M EUR
3.32 B EUR
81.07 M
About IDEXX Laboratories, Inc.
Sector
Industry
CEO
Jonathan J. Mazelsky
Website
Headquarters
Westbrook
Founded
1983
FIGI
BBG000GBSSK3
IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing markets. It operates through the following segments: Companion Animal Group (CAG), Water Quality Products (Water), Livestock, Poultry, and Dairy (LPD), and Other. The CAG segment provides diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment offers innovative testing solutions for easy, rapid, and accurate detection and quantification of various microbiological parameters in water. The LPD segment develops diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, to improve producer efficiency, and to ensure the quality and safety of milk and food. The Other segment is composed of products for the human point-of-care medical diagnostics market with its out-licensing arrangements. The company was founded by David Evans Shaw on December 19, 1983, and is headquartered in Westbrook, ME.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of IX1 is 395.60 EUR — it has increased by 0.18% in the past 24 hours. Watch IDEXX LABORATORIES INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange IDEXX LABORATORIES INC stocks are traded under the ticker IX1.
IX1 stock has risen by 1.05% compared to the previous week, the month change is a −0.05% fall, over the last year IDEXX LABORATORIES INC has showed a −21.73% decrease.
We've gathered analysts' opinions on IDEXX LABORATORIES INC future price: according to them, IX1 price has a max estimate of 537.69 EUR and a min estimate of 413.24 EUR. Watch IX1 chart and read a more detailed IDEXX LABORATORIES INC stock forecast: see what analysts think of IDEXX LABORATORIES INC and suggest that you do with its stocks.
IX1 stock is 1.17% volatile and has beta coefficient of 1.26. Track IDEXX LABORATORIES INC stock price on the chart and check out the list of the most volatile stocks — is IDEXX LABORATORIES INC there?
Today IDEXX LABORATORIES INC has the market capitalization of 32.59 B, it has decreased by −2.32% over the last week.
Yes, you can track IDEXX LABORATORIES INC financials in yearly and quarterly reports right on TradingView.
IDEXX LABORATORIES INC is going to release the next earnings report on Feb 10, 2025. Keep track of upcoming events with our Earnings Calendar.
IX1 earnings for the last quarter are 2.51 EUR per share, whereas the estimation was 2.41 EUR resulting in a 4.46% surprise. The estimated earnings for the next quarter are 2.30 EUR per share. See more details about IDEXX LABORATORIES INC earnings.
IDEXX LABORATORIES INC revenue for the last quarter amounts to 876.18 M EUR, despite the estimated figure of 880.47 M EUR. In the next quarter, revenue is expected to reach 897.08 M EUR.
IX1 net income for the last quarter is 209.12 M EUR, while the quarter before that showed 189.80 M EUR of net income which accounts for 10.18% change. Track more IDEXX LABORATORIES INC financial stats to get the full picture.
No, IX1 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 30, 2024, the company has 11.00 K employees. See our rating of the largest employees — is IDEXX LABORATORIES INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. IDEXX LABORATORIES INC EBITDA is 1.11 B EUR, and current EBITDA margin is 32.98%. See more stats in IDEXX LABORATORIES INC financial statements.
Like other stocks, IX1 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IDEXX LABORATORIES INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So IDEXX LABORATORIES INC technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating IDEXX LABORATORIES INC stock shows the sell signal. See more of IDEXX LABORATORIES INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.